CXCL14 and neoplasm: Additionally, injection of DAC together with cetuximab in YCU-H891 tumor-bearing mice stimulated CXCL14 expression in the tumor and suppressed tumor growth, indicating that CXCL14 was a marker for tumor suppression by cetuximab [14].